Kausik Umanath

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

David C. Wheeler, Robert D. Toto, Bergur V. Stefánsson et al. · Kidney International · 2021 · 397 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

David C. Wheeler, Bergur V. Stefánsson, Oleksandr Bilchenko et al. · Nephrology Dialysis Transplantation · 2020 · 190 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)

Michael V. Rocco, Kaycee M. Sink, Laura Lovato et al. · American Journal of Kidney Diseases · 2017 · 130 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD

Kausik Umanath, Diana Jalal, Barbara Greco et al. · Journal of the American Society of Nephrology · 2015 · 121 citations · Full text

Medicine, Hematology, Pharmacotherapy +17